Industry Perspectives

Covaris launches truCOLLECT for decentralized blood collection and DNA extraction

The new truCOLLECT Solution enables at-home fingerstick blood collection with ambient storage and shipment for genomic analysis.
Written byCovaris
| 2 min read
The truCOLLECT solution

CREDIT: Covaris

Register for free to listen to this article
Listen with Speechify
0:00
2:00

WOBURN, MA, UNITED STATES, April 8, 2026 /EINPresswire.com/ -- Covaris, a PerkinElmer company specializing in sample preparation technologies for the life sciences, today announced the launch of its truCOLLECT Solution, a novel integrated system for remote whole blood collection, stabilization, and downstream processing.

The truCOLLECT device is an FDA Class I-listed device and designed for capillary blood collection via fingerstick. The Solution immobilizes and stabilizes whole blood at the point of collection, enabling ambient storage and shipment without cold-chain requirements. Users can safely collect blood by finger stick in the comfort of their home and send samples to laboratories for downstream analysis, such as genomic analysis.

It is designed to address pre-analytical variability and logistical constraints associated with venipuncture-based collection, particularly in decentralized and geographically distributed studies. By enabling convenient self-collection, truCOLLECT supports broader participant recruitment, including pediatric, rural, and mobility-limited populations.

“The truCOLLECT Solution provides significant advantages for minimally invasive self-collection of blood samples in community-based, rural, and resource-limited settings”, said Elinette Albino, Associate Professor at the University of Puerto Rico. “These attributes make it particularly valuable for our pediatric research studies. The broad use of the truCOLLECT Solution can increase inclusivity and reduce participant burden for any population-based genomics initiative.”

Using proprietary chemistry, truCOLLECT enables extraction of assay-ready DNA directly from immobilized whole blood. The workflow is compatible with automation and is designed to produce consistent DNA yield and quality suitable for downstream applications, including next-generation sequencing.

When paired with Covaris’ truCOVER® Library Preparation kits, the system provides end-to-end workflow from at-home sample collection to DNA ready for sequencing. This integration reduces manual handling steps, supports reproducibility across sample batches, ensures improved cost/sample, ultimately enabling more effective testing.

“truCOLLECT was developed to simplify and standardize blood-based genomic workflows outside of traditional clinical settings,” said Annemarie Watson, CEO of Covaris. “By integrating remote collection with robust DNA extraction and library preparation, the platform enables high-quality data generation while reducing logistical complexity and cost.”

Key technical features of the truCOLLECT Solution include:

  • Capillary whole blood collection with on-device stabilization and ambient shipping
  • Elimination of cold-chain requirements during storage and transport
  • Direct extraction of molecular assay-ready DNA from immobilized samples
  • Compatibility with automated laboratory workflows
  • Reproducible DNA yields over 1.5 mg with superior quality across samples and batches
Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

Here are some related topics that may interest you:

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

3D illustration of a membrane protein embedded within a lipid nanodisc, representing a native-like environment used for membrane protein stabilization and characterization.
Mass photometry supports membrane protein characterization by providing rapid insights into sample composition, purity, and molecular assembly.
3D illustration of a protein complex composed of clustered spherical subunits arranged in a ring-like oligomeric structure, shown in shades of blue, cyan, and purple against a blue gradient background.
Automated mass photometry helps reveal the complex dynamics of protein oligomerization and the factors that govern protein assembly.
Illustration of translucent Y-shaped antibodies floating in a soft blue and green background, representing antibody research, development, and biomedical science.
Explore how antibody accessibility and custom development strategies can influence the pace and success of translational research.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue